Dr. Shalin Shreyaskumar Patel, MD

Dr. Patel practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Patel's NPI, 1316328826, was assigned on June 11, 2015. Dr. Patel graduated from Harvard Medical School in 2015. Dr. Patel holds Texas license T6347.

Dr. Patel's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Patel's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Patel to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Patel is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Patel's licenses on file in 4 states: Texas, Missouri, Delaware and Maryland.

Dmand AI lists joint or bone infection, joint pain, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, pelvic and hip fracture, scoliosis and spinal fusion among the conditions Dr. Patel treats.

CMS data shows 29 Medicare services from Dr. Patel across 1 procedure code in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $2,779 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 69, with 53% women.

In 2021, Dr. Patel wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $106 in total drug cost. In 2020, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Patel, published from 2020 to 2022. Dr. Patel's most frequent co-authors are Shalin S. Patel, MD, Abhiram R. Bhashyam, MD, PhD and Justin Earl Bird, MD.

CMS Open Payments shows 150 general payments to Dr. Patel from 19 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 52% of the total. Nuvasive, Inc. paid the most, $5,701.

Dr. Patel graduated from Harvard Medical School in 2015.

Dr. Patel is in network with 4 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.